Cancer Screening.Pdf
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Current Awareness Service, February, 2011
Current Awareness Services February 2011 American Journal of Epidemiology Volume 172, Issue 7 (1October 2010) How to Be a Department Chair of Epidemiology: A Survival Guide Roberta B. Ness and Jonathan M. Samet Pages: 747-751 A Pooled Analysis of Extremely Low-Frequency Magnetic Fields and Childhood Brain Tumors L. Kheifets, A. Ahlbom, C. M. Crespi, M. Feychting, C. Johansen, J. Monroe, M. F. G. Murphy, S. Oksuzyan, S. Preston-Martin, E. Roman, T. Saito, D. Savitz, J. Schüz, J. Simpson, J. Swanson, T. Tynes, P. Verkasalo, and G. Mezei Pages: 752-761 ORIGINAL CONTRIBUTION A Melanoma Epidemic in Iceland: Possible Influence of Sunbed Use Clarisse Héry, Laufey Tryggvadóttir, Thorgeir Sigurdsson, Elínborg Ólafsdóttir, Bardur Sigurgeirsson, Jon G. Jonasson, Jon H. Olafsson, Mathieu Boniol, Graham B. Byrnes, Jean-François Doré, and Philippe Autier Pages: 762-767 Invited Commentary: Invited Commentary: A Sunbed Epidemic? Marianne Berwick Pages: 768-770 Response to Invited Commentary: Autier et al. Respond to “A Sunbed Epidemic?” Philippe Autier, Laufey Tryggvadóttir, Thorgeir Sigurdsson, Elínborg Ólafsdóttir, Bardur Sigurgeirsson, Jon G. Jonasson, Jon H. Olafsson, Graham B. Byrnes, Clarisse Héry, Jean- François Doré, and Mathieu Boniol Pages: 771-772 Alcoholic Beverages and Prostate Cancer in a Prospective US Cohort Study Joanne L. Watters, Yikyung Park, Albert Hollenbeck, Arthur Schatzkin, and Demetrius Albanes Pages: 773-780 The Potentially Modifiable Burden of Incident Heart Failure Due to Obesity: The Atherosclerosis Risk in Communities Study Laura R. Loehr, Wayne D. Rosamond, Charles Poole, Ann Marie McNeill, Patricia P. Chang, Anita Deswal, Aaron R. Folsom, and Gerardo Heiss Pages: 781-789 Chronic and Acute Effects of Coal Tar Pitch Exposure and Cardiopulmonary Mortality Among Aluminum Smelter Workers Melissa C. -
Operational Guidance Forvictim Assistance Responsive to Gender
Victim assistance responsive to gender and other diversity aspects OPERATIONAL GUIDANCE The present publication was produced thanks to the financial support of the Italian Cooperation. Its content, however, is the sole responsibility of GMAP and does not reflect the views of the Italian Government. Table of contents List of abbreviations 5 Acknowledgments 6 Foreword 8 Introduction 11 Purpose of the operational guidance 14 Audience 15 Methodology 16 Limitations 17 Definitions 17 Structure 21 Services 23 Understanding the challenges (data collection) 23 Emergency and ongoing medical care 30 Rehabilitation 31 Psychological and psycho-social support 34 Socio-economic inclusion 37 Laws and policies 43 Affected States 45 Donors 49 Sources 51 Guidelines and Reports 51 Academic articles 55 Blogs, study cases and witnesses 57 © Jorge Henao, Colombia, 2010. GMAP - Guidances 2018 - Abbreviations & Preface Abbreviations ACAP III: Afghan Civilian Assistance Program ALSO: Afghanistan Landmine Survivor Organisation APMBC: Anti-Personnel Mine Ban Convention CCD: Community Center for the Disabled CCM: Convention on Cluster Munitions CCW: Convention on Certain Conventional Weapons CEDAW: Convention on the Elimination of all forms of Discrimination Against Women CRC: Convention on the Rights of the Child CRPD: Convention on the Rights of Persons with Disabilities DCP: Disability Creation Process ERW: Explosive Remnants of War GMAP: Gender and Mine Action Programme HI: Humanity & Inclusion (formerly known as Handicap International) HQ: Headquarters ICF: -
Ipri Biennial Report 2015 - 2016
12/2016 Creation iPRI Africa 07/2016 12th NCID 07/2015 11th NCID 06/2011 07/2011 7th NCID Epidemiology and Biostatistics 02/2012 World Published Breast Cancer Report Published 12/2009 MOU 07/2014 10th NCID U. Dundee 07/2010 First Summer School 10/2013 State of Oncology 2013 07/2010 6th NCID Published iPRI 04/2009 iPRI Founded 06/2012 Boyle 07/2013 9th NCID awarded LLD (honoris causa) 12/2010 Boyle Inducted Hungarian Science Academy 09/2012 Autier PhD Erasmus University 07/2010 06/2013 Creation of World Prevention Alliance Strathclyde Institute of 01/2013 Founded Global Public Health at iPRI Mullie professorship VUB 03/2013 Alcohol: Science, Policy and Public Health Published iPRI Biennial Per indicium ad excellentia R e port 2015 - 2016 © iPRI 2017 Biennial Report International Prevention Research Institute 95 Cours Lafayette 69006 Lyon, France +33472171199 | www.i-pri.org | [email protected] 2015 - 2016 Are we moving too fast? Perhaps we are - going too fast. Perhaps we are driving ahead, leaving too many people behind, quite literally in the dust. Perhaps we are not doing enough for the disen- franchised in low resource countries and for the poorest among us. iPRI believes in progress. We believe in providing the best possible evidence for better global health. But we are doubly committed to ensuring that our knowledge be a conduit for better health, not just in privileged quarters, but in the most destitute ones as well. All scientific and policy roads must lead to prevention and better health for all. iPRI Biennial Report 2015 - 2016 ©2017, International Prevention Research Institute, Lyon, France Contents cannot be copied or otherwise reproduced without express consent of iPRI. -
The Journal of Disaster Studies and Management
Volume 13 No. 1 1989 The Journal of Disaster Studies and Management Contents Agriculture and Food Security in Ethiopia NICHOLAS WINER The Food and Nutrition Surveillance Systems of Chad and Mali: the "SAP" after two years P. AUTIER et al. The Relief Operation in Puno District, Peru, after the 1986 Floods of Lake Titicaca L. SZTORCH, V. GICQUEL and J.C. DESENCLOS The Role of Socio-Economic Data in Food Needs Assessment and Monitoring J. SHOHAM and E. CLAY Diet and Nutrition during Drought: an Indian Experience N. PRALHAD RAO A case Study of Social Behaviour in a Natural Disaster: the Olivares landslide (Spain) J.L.G. GARCIA and M.V.S. PARRA Experiences of Non-Governmental Organisations in the Targeting of Emergency Food Aid J. BORTON and J. SHOHAM Seminar on Bangladesh Floods H. BRAMMER International Conference on the greenhouse effect and coastal areas of Bangladesh H. BRAMMER Forthcoming Events Book Reviews Basil Blackwell for the Relief and Development Institute DISASTERS The Journal of Disaster Studies and Management EDITOR Fred Cuny, Intertect, Derrick Jelliffe, School of Charles Melville, Faculty of Dallas, Texas Public Health, University of Oriental Studies, Bruce Currey Winrock California, Los Angeles University of Cambridge international Institute for ^ ^echat. Centre de ASSISTANT EDITOR Agricultural Development, Recherche sur Susan York, Relief and Bangladesh 1'Epidemiologie des Development Institute lan Davis, Disaster Desastres, 1'Ecole de Sante EDITORIAL BOARD ^"^ puu ue Universite oxford^TT ^ oxfordo , ^ ' Hugh Brammer, Relief P^Y ^^ ' ^ Catholique de Louvain, and Development Institute Frances D'Souza, Dept. of Brussels (Book Reviews Editor) Biological Anthropology, _, , , University of Oxford /-i. -
Resource Mobilization: Methodological Guidelines
Resource Mobilization: Methodological Guidelines Mukesh Chawla Research Associate Data for Decision Making Project Department of Population and International Health Harvard School of Public Health Peter Berman Associate Professor of International Health Economics Department of Population and International Health Harvard School of Public Health August 1996 Data for Decision Making Project Table of Contents Acknowledgements ....................................................................................... 1 1. Introduction ........................................................................................... 2 2. Strategies for Resource Mobilization ........................................................ 5 3. Tax Revenues ......................................................................................... 8 4. User Charges ........................................................................................ 11 Design and Implementation of User Fees ....................................................... 12 Impact of User Fees on the Health System .................................................... 16 5. Health Insurance .................................................................................. 24 Design and Implementation of Insurance System ............................................ 27 Impact of Insurance on the Health System .................................................... 32 6. Guidelines for the DDM/HHRAA Field Case Studies ................................. 37 Objectives ............................................................................................... -
The Jules Bordet Institute Is Participating
Press release for immediate release Facing cancer: eat and move! Brussels, November 12, 2020 – On 12 November, the Jules Bordet Institute, the Belgian reference centre in the fight against cancer, is participating in Nutrition Day. The occasion to again stress the essential link between healthy eating combined with regular physical exercise and treatment against cancer. Eat and move: two health "assets" that are in your hands when facing this disease. Nutrition Day, an international audit of the nutrition of hospitalised patients – figures Initiated in 2006 by Vienna University and the European Society for Clinical Nutrition and Metabolism (ESPEN), every year Nutrition Day undertakes a vast international audit (64 countries) inside hospitalisation units. Carried out by dietetic and nutrition teams, this audit looks at the nutritional status of patients before and after a period of hospitalisation and its impact on mortality in the 30 days following the audit. The results raise serious questions. The analysis of the figures since 2006 shows that in Belgium 50% of patients eat less during the week prior to hospitalisation, 40% of patients experience an involuntary weight loss during the 3 months prior to hospitalisation, and 14% of patents eat nothing during their hospitalisation. The follow-up of patients 30 days following the audit shows an increased mortality (2% to 8%) among patients who lost weight or ate less before and/or during their hospitalisation. This was observed among all age groups but is more significant among elderly subjects. Findings that confirm the importance of nutritional care when treating patients. As a cancer patient, watch out for involuntary weight loss! When facing cancer it is important to consult a dietician so as to adopt an appropriate diet that makes it possible to control weight increases and losses. -
Section of Early Detection & Prevention (Edp)
SECTION OF EARLY DETECTION & PREVENTION (EDP) THE SECTION OF EARLY DETECTION AND PREVENTION COMPRISES THREE GROUPS: Section Head THE PREVENTION GROUP (PRE), THE QUALITY ASSURANCE GROUP (QAS) AND THE Dr Rengaswamy Sankaranarayanan SCREENING GROUP (SCR). The Section seeks to provide evidence as to which primary and secondary prevention interventions are appropriate, effective and cost-effective in lowering the global burden of breast, cervical, oral, colorectal, skin and prostate cancers. This approach includes studying the means to implement integrated and quality-assured interventions in routine settings in different parts of the world. These research topics are in tune with the overall mission of the Agency in that they aim to reduce cancer burden by prevention. SECTION OF EARLY DETECTION & PREVENTION 105 106 biENNIAL REPORT 2008/2009 PREVENTION GROUP (PRE) Group Head Dr Philippe Autier Scientists Dr Mathieu Boniol Dr Graham Byrnes (until April 2009-moved to CIN/BST) Secretariat Ms Asiedua Asante Ms Anne Sophie Hameau (until March 2008) Ms Laurence Marnat (February 2008-May 2008) Visiting scientists Prof Brian Cox (from June 2008 to December 2008) Dr Jean-Francois Dore Dr Jan Alvar Lindencrona (until March 2008) Ms Carolyn Nickson (March 2009-May 2009) Prof Peter Selby (July 2009-December 2009) Ms Mary Jane Sneyd (June 2009-December 2009) Clerks Ms Murielle Colombet (until December 2008) Myriam Adjal (until February 2009) Students Lorraine Bernard (February 2008-August 2008) Maria Bota (July 2008-August 2008) Anne Elie Carsin (January 2008-April 2008) Gwendoline Chaize (May 2008-August 2008) Clementine Joubert (March 2008-August 2008) Alice Koechlin (May 2009-August 2009) Anthony Montella (June 2008-August2008) PhD students: Clarisse Hery (from June 2008) Isabelle Chaillol (from October 2008) PREVENTION GROUP 107 THE OVERALL GOAL OF THE PREVENTION GROUP IS TO EVALUATE THE IMPACT OF PREVENTION ACTIVITIES. -
SCIENTIFIC REPORT 2020 for the Years 2016 to 2019 Table of Contents
SCIENTIFIC REPORT 2020 For the years 2016 to 2019 Table of Contents 3 Foreword 4 Research in Numbers 7 Strategic Vision 9 Research Pillars 10 Pillar I: Dissecting Tumour Survival Mechanisms and Tumour Microenvironment 18 Pillar II: Tracking and Targeting Minimal Residual Disease 22 Pillar III: Next Generation Molecular Imaging to Better Personalise Treatment 27 Pillar IV: Accelerating Anticancer Drug Development 33 Pillar V: Developing New Approaches to Patient Empowerment and Well-being 40 New facilities will bring new opportunities for research 41 Organisation of Research Governance Research Support Units 48 Collaborations 51 Funding Les Amis de l’Institut Bordet Research Grants 54 Visiting Medical Research Fellows (2016-2019) 55 Awards 56 Publications 2016-2019 2016-2019 (Selected Papers) Publications 2019 79 Abbreviations 2 Foreword Dominique de Valeriola General Medical Director Institut Jules Bordet is a public and academic OECI*-certified comprehensive cancer center playing an important role in cancer care, research and education, both in Belgium and internationally. Entirely dedicated to adult cancer patients since its creation in 1939, it belongs to the City of Brussels and the Université Libre de Bruxelles. Both translational and clinical research are part of the Institute’s DNA, aiming to bring research discoveries to the patient’s bedside quickly. The present 2016-2019 scientific report reflects the spirit of commitment and collaboration of the Institute’s healthcare professionals, researchers, and administrative support teams and, above all, of the patients who trust our teams and volunteer to participate in clinical trials. A concerted and well-rewarded effort has been made during these recent years to build a stronger partnership with patients in developing our clinical trials, and to establish more efficient, centralised governance and operational support for our research activities. -
Mammography Screening Shows Limited Effect on Breast Cancer Mortality in Sweden
Journal of the National Cancer Institute Contact: Zachary Rathner [email protected] 301-841-1286 CI Mammography Screening Shows Limited Effect on Breast Cancer Downloaded from https://academic.oup.com/jnci/article/104/14/NP/2517022 by guest on 01 October 2021 Mortality in Sweden Breast cancer mortality statistics in Sweden are consistent with studies that have reported that screening has limited or no impact on breast cancer mortality among women aged 40-69, according to a study published July 17 in the Journal of the National Cancer Institute. Since 1974, Swedish women aged 40-69 have increasingly been offered mammography screening, with nationwide cover- age peaking in 1997. Researchers set out to determine if mortality trends would be reflected accordingly. In order to determine this, Philippe Autier, M.D., of the International Prevention Research Institute (iPRI) in France and colleagues, looked at data from the Swedish Board of Health and Welfare from 1960-2009 to analyze trends in breast cancer mortality in women aged age 40 and older by the county in which they lived. The researchers compared actual mortality trends with the theoretical outcomes using models in which screening would result in mortality reductions of 10%, 20%, and 30%. The researchers expected that screening would be associated with a gradual reduction in mortality, especially because Swedish mammography trials and observational studies have suggested that mammography leads to a reduction in breast cancer mortality. In this study, however, they found that breast cancer mortality rates in Swedish women started to decrease in 1972, before the introduction of mammography, and have continued to decline at a rate similar to that in the prescreening period. -
Institut Jules Bordet
Press release for immediate release A national health plan for cancer patients to avoid a wave of collateral victims! Brussels, 10 April 2020 – The crisis linked to the Covid-19 virus is currently responsible for a slowdown across the range of care needed in the treatment of cancer. As cancer is a major cause of mortality in Belgium the consequences of this must not be under- estimated. The Jules Bordet Institute, the Belgian reference centre for comprehensive cancer treatment, would already like to draw your attention to the measures that will have to be rapidly implemented. The pandemic caused by the Covid-19 virus is at the origin of an exceptional health situation. Every effort is currently being mobilised, among the general population, in medical circles and at the political level. The Jules Bordet Institute fully supports and is fully engaged in this combat. Nevertheless, in the field of cancer many patients do not at present have access to the necessary care in terms of screening, diagnosis, treatment and monitoring of their illness. This situation, imposed by the urgency and scale of the current problem, risks being the cause of a second wave of "collateral" victims of the COVID-19 virus. "Contrary to the viral epidemic, this second crisis is totally predictable. It is our responsibility to anticipate it and to envisage the collective measures necessary to limit the consequences. As soon as the pressure of the viral epidemic eases we must be able to resume optimal care for these patients. This is why, following on from the management of the present crisis, the treatment of cancer patients will require exceptional means, coordination and support from society as a whole," explains Vincent Donckier, Head of the Department of Surgery at the Jules Bordet Institute. -
Sunbed Use, Sunscreen Use, Childhood Sun Exposure, and Cutaneous Melanoma
Sunbed use, sunscreen use, childhood sun exposure, and cutaneous melanoma Philippe Autier Sunbed use, sunscreen use, childhood sun exposure, and cutaneous melanoma Philippe Autier 1 2 Sunbed use, Sunscreen use, Childhood Sun Exposure, and Cutaneous Melanoma Gebruik zonnebank, gebruik zonnecrèmes, blootstelling van de zon bij kinderen en melanoma van de huid Thesis To obtain the degree of Doctor from the Erasmus University Rotterdam by command of the rector magnificus Prof. dr. H.G. Schmidt, and in accordance with the decision of the Doctorate Board The public defence shall be held on Wednesday 12th of October 2011 at 11: 30 am by Philippe Autier Born in Naast (Belgium) 3 Doctoral Committee Promotors: Prof.dr. J.W.W. Coebergh Prof.dr. A.M.M. Eggermont Inner Committee: Prof.dr. A. Burdorf Prof. F. De Gruijl Prof.dr. H.A.M. Neumann Other members: Prof.dr. W. Bergman Prof.dr. R. Kanaar Prof.dr. R. MacKie Prof.dr. W.J. Mooi 4 For Anne, Anton and Gilles 5 Table of content Section 1: Preface Section 2: Artificial UV tanning Background as of 1992 Overview of ecological and observational studies Reviews and meta‐analyses Further data from descriptive studies Epidemiological or human experiments data supporting out findings Epidemiological or human experiments data challenging out findings Articles displayed as part of this section Section 3: Sunscreens and wearing of clothes Background as of 1992 Overview of observational studies on 5‐MOP sunscreens Overview of observational studies on sunscreens Randomised controlled trials Reviews Epidemiological -
Jules Bordet Institute - with a Team of Belgian and International Colleagues, Was Founded with This Aim in Mind
Press release for immediate release Oncodistinct, a multidisciplinary clinical research network that meets patients' needs Brussels, 23 May 2018 – Cancer research is advancing by leaps and bounds with fast changing developments in cancer treatment. To respond to these changes, clinical research in cancerology must also change. Today there is a real need for new structures that facilitate the pooling of expertise and resources to better meet patients' needs and accelerate the development of new medicines in the fight against cancer. Oncodistinct, a multidisciplinary clinical research network set up by Professor Awada - Head of Medicine and the Medical Oncology Unit at the Jules Bordet Institute - with a team of Belgian and international colleagues, was founded with this aim in mind. A network of 27 cancer centres and university hospitals, Oncodistinct will be holding its bi-annual meeting on 24 May at the Paoli Calmettes Institute in Marseille. Oncodistinct is a multidisciplinary clinical research network set up in November 2015. Its objective is to adapt clinical trial methodology to recent innovations in treatment and accelerate the development of anti-cancer drugs for solid tumours, in particular in situations for which no standard treatment currently exists. As such, the network is seeking to respond to unmet medical needs, especially in the field of brain metastases and rare tumours. The network today has 27 members in all (11 cancer centres and 16 university hospitals) that pool their expertise in oncology and the development of anti-cancer medicines. Members of the Oncodistinct network meet twice yearly to jointly initiate innovative multicentre trials with the aim of improving treatment for cancer patients.